Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BOTULINUM TOXIN TYPE A vs BRENTUXIMAB VEDOTIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BOTULINUM TOXIN TYPE A vs BRENTUXIMAB VEDOTIN: Safety Overview

Metric BOTULINUM TOXIN TYPE A BRENTUXIMAB VEDOTIN
Total FAERS Reports 3,742 9,724
Deaths Reported 1,288 1,922
Death Rate 34.4% 19.8%
Hospitalizations 1,536 3,781
Average Patient Age 44.1 yrs 49.7 yrs
% Female Patients 78.8% 41.6%
Manufacturer Evolus, Inc. SEAGEN INC.
Route INTRAMUSCULAR INTRAVENOUS
Marketing Status N/A Prescription